Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial
PaperCitations, authors & open-access status
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 159 citations, 2020 year and bronze oa status.
159
Citations
2020
Year
bronze
OA Status